RP-HPLC bioanalytical method development and validation for the estimation of Escitalopram in human plasma
BIOCHEMICAL AND CELLULAR ARCHIVES · 03.03.2026 · 26 (1) · 881-886
DOI: 10.51470/bca.2026.26.1.881 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIOCHEMICAL AND CELLULAR ARCHIVES, online erschienen am 09.03.2026. Verfasst von Santosh Karajgi und 7 weiteren Autor:innen.
Abstract (Originalsprache)
For the simultaneous measurement of escitalopram in human plasma using reverse-phase high-performance liquid chromatography (RP-HPLC), a solid-phase extraction technique was created. As an internal standard, tinidazole was employed. Using 0.2% ortho phosphoric acid and acetonitrile in a 65:35% v/v ratio as the mobile phase, samples were separated on an Enable C18 column at a flow rate of 1.0 ml/min at room temperature. At 240 nm, detection was done. For escitalopram, calibration plots were linear (R² > 0.9960) across the 100–800 ng/ml concentration range. In accordance with ICH requirements, all analytical validation parameters were established. Since accuracy, precision, recovery, and other validation criteria fell within the guidelines’ defined bounds, the bioanalytical method that was created was robust, selective, and dependable. For escitalopram, the overall recovery rate was 99.75%. The intra-day precision was 5.34%, and the inter-day precision was 6.31%. Human plasma pharmacokinetics was successfully studied using the proven approach. The technique can be highly beneficial for biomedical research, bioequivalence studies, and therapeutic drug monitoring (TDM).
Zitieren
APA
Karajgi, S., Anusuya, A. M., Surekha, M. L., Paramel, L. J., Firake, B. M., Kavitha, C., Gupta, S. K., & Sonam, K. (2026). RP-HPLC bioanalytical method development and validation for the estimation of Escitalopram in human plasma. BIOCHEMICAL AND CELLULAR ARCHIVES, 26(1), 881-886. https://doi.org/10.51470/bca.2026.26.1.881
Vancouver
Karajgi S, Anusuya AM, Surekha ML, Paramel LJ, Firake BM, Kavitha C, et al. RP-HPLC bioanalytical method development and validation for the estimation of Escitalopram in human plasma. BIOCHEMICAL AND CELLULAR ARCHIVES. 2026;26(1):881-886. doi:10.51470/bca.2026.26.1.881
BibTeX
@article{Karajgi2026,
author = {Karajgi, Santosh and Anusuya, A. M. and Surekha, M. L. and Paramel, Lydia Jeeboi and Firake, Bhushan M. and Kavitha, C. and Gupta, Shiv Kumar and Sonam, Km.},
title = {RP-HPLC bioanalytical method development and validation for the estimation of Escitalopram in human plasma},
journal = {BIOCHEMICAL AND CELLULAR ARCHIVES},
year = {2026},
volume = {26},
number = {1},
pages = {881--886},
doi = {10.51470/bca.2026.26.1.881}
}
EUVIMED